4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001104659-21-140226
Chief Financial Officer acquired 118,916 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Dalgleish Scott · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-12 | Grant or award : show line 1 in the form | +47,566 | 47,566 | D |
| 2021-11-12 | Grant or award : show line 2 in the form | +71,350 | 118,916 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-12 | Grant or award : show line 3 in the form Stock Options (right to buy) | +261,023 | 261,023 | D |
| 2021-11-12 | Grant or award : show line 4 in the form Stock Options (right to buy) | +350,876 | 350,876 | D |
Loading xslF345X03/tm2132979d17_4seq1.xml…